Inventor · disambiguated record
Derek John Londesbrough
Also filed as: LONDESBROUGH DEREK · LONDESBROUGH DEREK J · LONDESBROUGH DEREK JOHN
34 granted patents·16 pending applications·363 citations·filing 2006–2025
98Inventor score
Files withCOMPASS PATHFINDER LTD23CYBIN UK LTD4ZOGENIX INTERNATIONAL LTD4BERGENBIO ASA3BECK PETRA HELGA2
Top patents by PatentIndex Score
50 records- 0198US11939346B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2023·Granted Mar 26, 2024·6 cites·28 claims
- 0298US11634377B2Fenfluramine compositions and methods of preparing the sameZOGENIX INTERNATIONAL LTD·Filed 2021·Granted Apr 25, 2023·5 cites·16 claims
- 0398US11629159B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2022·Granted Apr 18, 2023·10 cites·30 claims
- 0498US11180517B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2021·Granted Nov 23, 2021·22 cites·25 claims
- 0598US11149044B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2021·Granted Oct 19, 2021·18 cites·22 claims
- 0698US10954259B1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2020·Granted Mar 23, 2021·22 cites·23 claims
- 0798US10947257B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2020·Granted Mar 16, 2021·23 cites·23 claims
- 0897US11851451B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2022·Granted Dec 26, 2023·5 cites·30 claims
- 0997US11505564B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2019·Granted Nov 22, 2022·13 cites·26 claims
- 1097US11447510B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2021·Granted Sep 20, 2022·13 cites·27 claims
- 1196US10519175B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHWAYS LTD·Filed 2018·Granted Dec 31, 2019·51 cites·21 claims
- 1295US12447164B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2023·Granted Oct 21, 2025·3 cites·33 claims
- 1395US11643390B2Synthesis of N,N-dimethyltryptamine-type compounds, methods, and usesSMALL PHARMA LTD·Filed 2021·Granted May 9, 2023·9 cites·20 claims
- 1495US11578039B2CompoundsSMALL PHARMA LTD·Filed 2022·Granted Feb 14, 2023·9 cites·14 claims
- 1595US11564935B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2021·Granted Jan 31, 2023·9 cites·27 claims
- 1695US10351510B2Fenfluramine compositions and methods of preparing the sameZOGENIX INTERNATIONAL LTD·Filed 2018·Granted Jul 16, 2019·16 cites·18 claims
- 1795US10351509B2Fenfluramine compositions and methods of preparing the sameZOGENIX INTERNATIONAL LTD·Filed 2016·Granted Jul 16, 2019·16 cites·22 claims
- 1894US11865126B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2023·Granted Jan 9, 2024·5 cites·30 claims
- 1994US11738035B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2022·Granted Aug 29, 2023·6 cites·29 claims
- 2093US10947183B2Fenfluramine compositions and methods of preparing the sameZOGENIX INTERNATIONAL LTD·Filed 2019·Granted Mar 16, 2021·10 cites·33 claims
- 2192US12312375B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2024·Granted May 27, 2025·0 cites·30 claims
- 2291US12157723B2CompoundsCYBIN UK LTD·Filed 2023·Granted Dec 3, 2024·1 cites·20 claims
- 2391US7692006B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2007·Granted Apr 6, 2010·28 cites·7 claims
- 2491US2025361251A1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 2591US2025368665A1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 2690US12433904B2Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2020·Granted Oct 7, 2025·2 cites·32 claims
- 2790US2024199660A1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2024·Application pending·0 cites
- 2889US8207187B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsBECK PETRA HELGA·Filed 2006·Granted Jun 26, 2012·20 cites·16 claims
- 2989US2025367223A1Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybinCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 3088US8247416B2Phthalazinone derivativeMENEAR KEITH ALLAN·Filed 2009·Granted Aug 21, 2012·20 cites·4 claims
- 3188US2025304607A1Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 3287US10493071B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsHELPERBY THERAPEUTICS LTD·Filed 2017·Granted Dec 3, 2019·7 cites·2 claims
- 3386US9694006B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsBECK PETRA HELGA·Filed 2012·Granted Jul 4, 2017·12 cites·9 claims
- 3486US2025302851A1Methods of treating neurocognitive disorders, chronic pain and reducing inflammationCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 3585US2025042852A1CompoundsCYBIN UK LTD·Filed 2024·Application pending·0 cites
- 3684US12377112B2Methods of treating neurocognitive disorders, chronic pain and reducing inflammationCOMPASS PATHFINDER LTD·Filed 2020·Granted Aug 5, 2025·1 cites·27 claims
- 3784US2024217929A1Synthesis of n,n-dimethyltryptamine-type compounds, methods, and usesCYBIN UK LTD·Filed 2024·Application pending·0 cites
- 3881US12084417B2Synthesis of N,N-dimethyltryptamine-type compounds, methods, and usesCYBIN UK LTD·Filed 2023·Granted Sep 10, 2024·0 cites·19 claims
- 3979US12459965B2Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useCOMPASS PATHFINDER LTD·Filed 2024·Granted Nov 4, 2025·0 cites·10 claims
- 4069US10336702B2Pharmaceutically active compoundsBERGENBIO ASA·Filed 2015·Granted Jul 2, 2019·1 cites·28 claims
- 4163US10766861B2Pharmaceutically active compoundsBERGENBIO ASA·Filed 2019·Granted Sep 8, 2020·0 cites·9 claims
- 4263US2024010628A1Methods of manufacture of r-mdmaMIND MEDICINE INC·Filed 2023·Application pending·0 cites
- 4362US2021070708A1Pharmaceutically Active CompoundsBERGENBIO ASA·Filed 2020·Application pending·0 cites
- 4459US2025162980A1Methods for preparing mescalineJOURNEY COLAB CORP·Filed 2023·Application pending·0 cites
- 4556US2024245632A1Methods of treating substance use disorders using mescalineJOURNEY COLAB CORP·Filed 2022·Application pending·0 cites
- 4654US2024287035A1Preparation of a chk1 inhibitor compoundSENTINEL ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 4752US2024228479A1Process for synthesizing 2-bromolysergic acid diethylamide via controlled bromination of lysergic acidCERUVIA LIFESCIENCES LLC·Filed 2023·Application pending·0 cites
- 4847US10927113B2Process for preparing purine derivativesCYCLACEL LTD·Filed 2018·Granted Feb 23, 2021·0 cites·14 claims
- 4947US2022348565A1Pharmaceutical compoundsSENTINEL ONCOLOGY LTD·Filed 2020·Application pending·0 cites
- 5042US2023104823A1Process for the preparation of purine derivatives exhibiting cdk inhibitory activityCYCLACEL LTD·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →